It would seem that ZYNE got a bit ahead of itself. We were very extended on 26, 29 and 30 April, and finally saw some healthy consolidation with an initial 5% pull back. SPY was making ripples yesterday, and probably added much to panic reaction, more than 20% down. I bought that dip with much gratitude, and relished when buying pressure forced her back up to $11.40.
If we assume that the recent high of $13.06 marks the end of this cycle, we'll probably see some lower highs and lower lows/higher lows, leading the price back to the 45 degree line, most likely keeping the range roughly between $10 and $12 for now. On the other hand, if bulls break the $13 price resistance, we'll see another leg up. Perhaps that is why we always say "levels on watch".
I expect the 45 degree trend line to be strong, as it has been 'touched' 3 times. Keep in mind that ZYNE is only just starting on its rebound journey upward. If you think you've missed it, I think you're wrong. I think the entry is now, with targets of $15 within weeks, and $25 and $36 within the next 6 to 8 months. What we're hoping to see from ZYNE, is a great Phase 3 trial results, and for the broader market, the legalisation of CBD as an additive, etc. so that Zynerba can start marketing its wide range of unique patents.
When that bit is behind us, CBD legalisation in the European Union is next. Also for GWPH, btw.
Safe trading, everybody!
If we assume that the recent high of $13.06 marks the end of this cycle, we'll probably see some lower highs and lower lows/higher lows, leading the price back to the 45 degree line, most likely keeping the range roughly between $10 and $12 for now. On the other hand, if bulls break the $13 price resistance, we'll see another leg up. Perhaps that is why we always say "levels on watch".
I expect the 45 degree trend line to be strong, as it has been 'touched' 3 times. Keep in mind that ZYNE is only just starting on its rebound journey upward. If you think you've missed it, I think you're wrong. I think the entry is now, with targets of $15 within weeks, and $25 and $36 within the next 6 to 8 months. What we're hoping to see from ZYNE, is a great Phase 3 trial results, and for the broader market, the legalisation of CBD as an additive, etc. so that Zynerba can start marketing its wide range of unique patents.
When that bit is behind us, CBD legalisation in the European Union is next. Also for GWPH, btw.
Safe trading, everybody!
🅱🄰🆁🅺🆆🄾🆁🆃🅷